A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial Assessing the Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma-Associated Raynaud's Phenomenon

Local injections with Botulinum Toxin Type-A (Btx-A) will improve blood flow to the hands of patients with Raynaud ’s phenomenon secondary with scleroderma, as measured by Laser Doppler Imaging and patient-reported outcomes.

Source: The Journal of Hand Surgery - August 25, 2016 Category: Surgery Authors: Ricardo J. Bello, Carisa M. Cooney, Eitan Melamed, Keith E. Follmar, Fred J. Wigley, Scott D. Lifchez Tags: Abstract Source Type: research